Literature DB >> 7661160

Variability with omeprazole-amoxicillin combinations for treatment of Helicobacter pylori infection.

K S Graham1, H Malaty, H M el-Zimaity, R M Genta, R A Cole, M T al-Assi, M M Yousfi, G A Neil, D Y Graham.   

Abstract

OBJECTIVE: Although omeprazole co-therapy enhances the effectiveness of some antimicrobials for the treatment of Helicobacter pylori infection, results have not been uniform. A meta-analysis suggested that 20 mg of omeprazole b.i.d. and 2 g or more of amoxicillin would yield a > 80% success rate (Gastroenterology 1994; 106: 142A). Our objective in this study was to test that hypothesis.
METHODS: Volunteers with H. pylori infection were studied. Anti-H. pylori therapy was administered with meals for 14 days (omeprazole 20 mg b.i.d. plus amoxicillin 1 g t.i.d., or omeprazole 20 mg b.i.d. plus amoxicillin 0.5 g t.i.d.). Endoscopy was performed 4-6 wk after antimicrobial therapy ended, and the presence or absence of H. pylori was determined with biopsy specimens by Genta stain.
RESULTS: Fifty-nine volunteers completed the study; 30 were studied twice. The overall success for initial treatment with either combination of amoxicillin and omeprazole was 18 of 59 [30.5%; 95% confidence interval (CI) = 19-44%]. The success rate with 500 mg amoxicillin t.i.d. was 7 of 29 (24%; 95% CI = 10-43%). With 1 g t.i.d. amoxicillin, the cure rate was higher (36.6%) (11 of 30; 95% CI = 20-56%), or intention-to-treat result was 11 of 31 (35.4%), which includes the early dropout. Compliance was > 95% for both therapies. Side effects were experienced by eight patients, two receiving 1.5 g amoxicillin and six receiving 3 g amoxicillin (p > 0.2). German trials suggest that better results might be achieved when amoxicillin is given as suspension while fasting. Thirty treatment failures were re-treated with 1 g amoxicillin suspension t.i.d., given fasting, and omeprazole 20 mg b.i.d. The cure rate was 16.6% (95% CI = 6-35%).
CONCLUSION: Amoxicillin/omeprazole combinations for treatment of H. pylori infection do not yield consistent results. The reason is unknown, but the reported high rate of success with 40 mg of omeprazole and 750 mg t.i.d. suggests that almost complete inhibition of acid secretion is necessary to obtain consistent results with this combination.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7661160

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  7 in total

Review 1.  Eradication of Helicobacter pylori Infection.

Authors:  Elizabeth A Marcus; George Sachs; David R Scott
Journal:  Curr Gastroenterol Rep       Date:  2016-07

2.  Dual proton pump inhibitor plus amoxicillin as an empiric anti-H. pylori therapy: studies from the United States.

Authors:  David Y Graham; Syed Ussama Javed; Sara Keihanian; Suhaib Abudayyeh; Antone R Opekun
Journal:  J Gastroenterol       Date:  2010-03-02       Impact factor: 7.527

Review 3.  Helicobacter pylori.

Authors:  B E Dunn; H Cohen; M J Blaser
Journal:  Clin Microbiol Rev       Date:  1997-10       Impact factor: 26.132

Review 4.  Omeprazole. A review of its use in Helicobacter pylori infection, gastro-oesophageal reflux disease and peptic ulcers induced by nonsteroidal anti-inflammatory drugs.

Authors:  H D Langtry; M I Wilde
Journal:  Drugs       Date:  1998-09       Impact factor: 9.546

Review 5.  Pharmacotherapy for acid/peptic disorders.

Authors:  M L Schubert
Journal:  Yale J Biol Med       Date:  1996 Mar-Apr

Review 6.  The role of acid inhibition in Helicobacter pylori eradication.

Authors:  David R Scott; George Sachs; Elizabeth A Marcus
Journal:  F1000Res       Date:  2016-07-19

7.  Failure of optimized dual proton pump inhibitor amoxicillin therapy: What now?

Authors:  David Y Graham; Hong Lu; Akiko Shiotani
Journal:  Saudi J Gastroenterol       Date:  2017 Sep-Oct       Impact factor: 2.485

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.